MedPath

Estimation of Functional Liver Reserve Using Cholinesterases

Completed
Conditions
Hepatocellular Carcinoma
Cirrhosis
Liver Neoplasm
Liver Disease
Registration Number
NCT00883454
Lead Sponsor
University of Milan
Brief Summary

Estimation of functional liver reserve in patients with hepatocellular carcinoma (HCC) in cirrhosis is of paramount importance to properly select candidates for surgical resection. Together with the value of bilirubin, the presence/absence of ascites and esophageal varices, and the rate of residual liver volume, which are our current parameters to measure functional liver reserve, the investigators sought to investigate the value of preoperative cholinesterases (CHE) in predict postoperative adverse outcome after hepatic resection for HCC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
181
Inclusion Criteria
  1. Total bilirubin < 2 mg/dl

  2. No ascites

  3. No esophageal varices, or esophageal varices eradicated by endoscopy

  4. Liver volume:

    • residual liver volume > or = 40% if total bilirubin < 1 mg/dl
    • residual liver volume > or = 50% if total bilirubin between 1 and 1.5 mg/dl
    • only limited resection if total bilirubin > 1.5 mg/dl
  5. Portal vein embolization was selected in any case in whom RLV did not fit the previous requirements.

Exclusion Criteria
  1. Total bilirubin > 2 mg/dl
  2. Refractory ascites
  3. Esophageal varices

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome was to investigate the value of preoperative cholinesterases in predict postoperative adverse outcome after hepatic resection for hepatocellular carcinoma in cirrhosis.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Liver Surgery Unit, Third Department of Surgery, University of MIlan, IRCCS Istituto Clinico Humanitas

🇮🇹

Rozzano, Milan, Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath